Spikevax (previously COVID‑19 Vaccine Moderna)
A Conditional Marketing Authorisation (CMA) has been granted in the EU for the product Spikevax (previously COVID‑19 Vaccine Moderna) to prevent coronavirus disease 2019 (COVID‑19) in people from 6 years of age.
Patient Information Leaflet
Patient Information Leaflet
Summary of Product Characteristics
Summary of Product Characteristics
Storage, Handling, Dosage and Administration
Storage, Handling, Dosage and Administration
Temperature Excursion Tool
Temperature Excursion Tool
See what to do with vials of the Moderna COVID-19 Vaccine that may have experienced a temperature excursion prior to administering.
Contact Moderna
8am-5pm CET – Mon - Fri
EMEAMedinfo@modernatx.com